Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
SCHW reports Q3 results on October 15 with the stock under pressure and analysts actively revising their views in opposite directions in the days before the print.
The most notable signal heading into earnings is the burst of analyst activity over the past ten days. Morgan Stanley raised its price target to $141 from $136 on October 9, keeping an Overweight rating, a vote of confidence in Schwab's multi-year earnings recovery thesis. The counterpoint arrived the same week: UBS cut its target to $113 from $128 and Barclays trimmed to $118 from $125, both maintaining positive ratings but signalling that valuation has become a harder sell after the stock's 10% pullback over the past month to $96.70. Bank of America, carrying an Underperform rating, raised its target modestly to $95, essentially flagging the stock as fairly valued at best. The mean consensus target of $123 implies roughly 27% upside from current levels, but the direction of travel among targets is mixed rather than uniformly constructive, and the stock trades below B of A's ceiling.
Bulls centre their case on the franchise's scale and the interest margin recovery story. Management guided FY26 revenue growth of 14% to 15% and a net interest margin exiting the year at 3.25% to 3.30%, with mid-teens EPS growth framed as achievable. The 30-day EPS momentum factor ranks in the 79th percentile and 90-day momentum in the 83rd, meaning estimate revisions have been tilting positive. Bears push back on several fronts: organic asset growth has slowed to under 2% in 2026, the "cash optimizer" thesis that bulls use to model margin expansion is contested by management's own commentary (Schwab describes client cash as highly transactional, with $3 trillion moving through the platform monthly), and competitive pressure on deposit pricing keeps the path to margin expansion narrower than the bull case implies. A 20% equity market drawdown scenario would compound the pressure on fee-based revenue.
Positioning in the lending market offers no signal of elevated short-side conviction. Short interest is just 1.1% of the free float, and while it has risen about 18% over the past month in share terms, the absolute level remains negligible for a stock of this size. Availability is essentially unconstrained, with borrow costs running below 0.5%. Options positioning is equally muted: the put/call ratio of 0.91 is fractionally below its 20-day average of 0.92, with a z-score of minus 0.28, showing no unusual hedging pressure. Peers have fared somewhat better on the week, with LPLA up 4.6% and CME up 6.6%, while SCHW ended the week flat. That relative lag into a broadly supportive week for financial stocks adds a small layer of caution to the setup.
One data point from ORTEX Alt Data adds texture without offering a directional read. Schwab's own bank charter, reported through FDIC call reports, has seen net loans and leases rise for nine consecutive quarters, reaching $67.2 billion as of April 2026, and net income from those charters has increased for seven consecutive quarters, reaching just over $1 billion in the same period. The FDIC dataset has not yet been tested as a leading indicator against Schwab's reported earnings, so it cannot be treated as a signal for the print, but the streak documents an improving underlying bank-level trend that forms part of the bull case.
The October 15 print is therefore less a test of whether Schwab's recovery is real and more a test of how quickly the margin trajectory is materialising, and whether management's commentary on the cash sorting dynamic gives the Street enough confidence to hold targets above $120.
See the live data behind this article on ORTEX.
Open SCHW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
